Mur ligases inhibitors with azastilbene scaffold: Expanding the structure-activity relationship

Martina Hrast1, Rok Frlan1, Damijan Knez1

  • 1Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia.

Insights

Novel azastilbene compounds show potential as new antibiotics by inhibiting essential bacterial Mur ligases (MurC-MurF). One compound demonstrated moderate antibacterial activity, offering hope against antibiotic resistance.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Antibiotic resistance is a critical global health threat.
  • Mur ligases (MurC-MurF) are essential for bacterial cell wall synthesis and represent promising antibacterial targets.

Purpose of the Study:

  • To synthesize and evaluate novel azastilbene scaffold inhibitors targeting Mur ligases.
  • To explore structure-activity relationships for Mur ligase inhibition.

Main Methods:

  • Chemical synthesis of azastilbene derivatives.
  • Biochemical assays to assess Mur ligase inhibition.
  • Structure-activity relationship (SAR) analysis.
  • Evaluation of antibacterial activity.

Main Results:

  • Several synthesized compounds exhibited potent inhibition against multiple Mur ligases.
  • One compound demonstrated moderate broad-spectrum antibacterial activity.
  • Established structure-activity relationships for the azastilbene scaffold.

Conclusions:

  • Azastilbene derivatives are promising scaffolds for developing new antibacterial agents.
  • Targeting Mur ligases offers a viable strategy to combat antibiotic resistance.
  • Further optimization could lead to clinically relevant antimicrobial drugs.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K